These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 5286778)

  • 1. The uses and abuses of L.S.D. and other hallucinogenic drugs.
    Barnes DT
    Aust N Z J Psychiatry; 1970 Dec; 4(4):170-3. PubMed ID: 5286778
    [No Abstract]   [Full Text] [Related]  

  • 2. The current status of the hallucinogenic drugs.
    Seal RE
    Aust N Z J Psychiatry; 1970 Jun; 4(2):64-7. PubMed ID: 5286790
    [No Abstract]   [Full Text] [Related]  

  • 3. The hallucinogenic drugs--their use and abuse.
    Med J Aust; 1968 Jan; 1(4):146-7. PubMed ID: 5641090
    [No Abstract]   [Full Text] [Related]  

  • 4. Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.
    Schindler EA; Gottschalk CH; Weil MJ; Shapiro RE; Wright DA; Sewell RA
    J Psychoactive Drugs; 2015; 47(5):372-81. PubMed ID: 26595349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence on LSD and other hallucinogenic drugs.
    JAMA; 1967 Oct; 202(1):141-4. PubMed ID: 6072003
    [No Abstract]   [Full Text] [Related]  

  • 6. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
    De Gregorio D; Enns JP; Nuñez NA; Posa L; Gobbi G
    Prog Brain Res; 2018; 242():69-96. PubMed ID: 30471683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysergic acid diethylamide.
    O'Shea B; Fagan J
    Ir Med J; 2001; 94(7):217. PubMed ID: 11693215
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychedelic drugs: the ups and downs of ecstasy.
    Check E
    Nature; 2004 May; 429(6988):126-8. PubMed ID: 15141183
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential.
    Rucker JJ
    BMJ; 2015 May; 350():h2902. PubMed ID: 26014506
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of cluster headache to psilocybin and LSD.
    Sewell RA; Halpern JH; Pope HG
    Neurology; 2006 Jun; 66(12):1920-2. PubMed ID: 16801660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Return of a problem child.
    Stix G
    Sci Am; 2009 Oct; 301(4):18, 20. PubMed ID: 19780439
    [No Abstract]   [Full Text] [Related]  

  • 13. The promises and perils of psychedelic pharmacology for psychiatry.
    McClure-Begley TD; Roth BL
    Nat Rev Drug Discov; 2022 Jun; 21(6):463-473. PubMed ID: 35301459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is the use of LSD-25 in experimental psychiatry and psychotherapy today still justifiable?].
    Leuner H
    Nervenarzt; 1968 Aug; 39(8):356-60. PubMed ID: 5712441
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
    Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J
    Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346
    [No Abstract]   [Full Text] [Related]  

  • 16. [LSD and related hallucinogens. History--effect--use and dangers].
    Hole G
    Munch Med Wochenschr; 1967 Jun; 109(26):1389-97. PubMed ID: 4874820
    [No Abstract]   [Full Text] [Related]  

  • 17. Visual disturbances experienced by hallucinogenic drug abusers while driving.
    Woody GE
    Am J Psychiatry; 1970 Nov; 127(5):683-6. PubMed ID: 5491546
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classic psychedelic drugs and their potential therapeutic effect].
    Bayat M
    Ugeskr Laeger; 2017 Sep; 179(37):. PubMed ID: 28918777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further observations regarding hallucinogenic treatment.
    Geert-Jörgensen E
    Acta Psychiatr Scand Suppl; 1968; 203():195-200. PubMed ID: 5248227
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
    Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL
    Psychol Med; 2020 Dec; 50(16):2655-2666. PubMed ID: 33143790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.